Navigation Links
Baxter International Fourth Quarter 2008 Financial Results Conference Call
Date:1/6/2009

DEERFIELD, Ill., Jan. 6 /PRNewswire-FirstCall/ -- Baxter International (NYSE: BAX), will host a quarterly conference call to discuss its fourth quarter 2008 financial results on Thursday, January 22, 2009, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). To access the call, please dial 866-238-0637 (domestic) or 703-639-1156 (international). Please dial into the call at least ten minutes prior to the start of the call for the operator to connect you.

This call is being webcast by Thomson/CCBN and can be accessed at Baxter's Web site at http://www.baxter.com/. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission.

The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (www.streetevents.com), a password-protected event management site.

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.


'/>"/>
SOURCE Baxter International
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers
2. Baxter International Second Quarter 2008 Financial Results Conference Call
3. Baxter Releases Ninth Annual Sustainability Report
4. John D. Baxter, M.D. Joins Bionovos Board of Directors
5. FDA Finds Contaminant in Baxters Recalled Heparin Products
6. Baxter Recalls Rest of Heparin Products
7. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
8. Baxter Reports Strong Third Quarter Sales and Earnings
9. Baxter International Third Quarter 2007 Financial Results Conference Call
10. Medical Simulation Corporation to Introduce Ventilator Associated Pneumonia Program at International Meeting on Simulation in Healthcare
11. Stem Cells Poised to Grow Organs for Transplant : Zannos Grekos, MD Presents Clinical Data of Research with Adult Stem Cells to Physicians at International Regenerative Biomedicine Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 2015 Sanjay Gupta, MD, CNN’s ... keynote address at ATA 2015, the American Telemedicine ... Show and world’s largest telemedicine, telehealth and mHealth ... medical correspondence for several of CNN’s headlining programs ... including his DuPont Award winning WEED series. He ...
(Date:3/6/2015)... Califia Farms , the fastest-growing ... products coffee drinks category, has been selected as a ... for its Double Espresso Pure Iced Coffee Almondmilk. ... test to find the best, healthiest and cleanest edible ... , “As a company dedicated to sustainable and mindful ...
(Date:3/6/2015)... San Jose, California (PRWEB) March 06, 2015 ... prosthetics and implants such as bridges and crowns, abutments ... suffering from conditions caused by decayed teeth and missing ... prosthetic and implant consumables is driven by an aging ... dental technologies. With about 4%-5% of the 65+ population ...
(Date:3/6/2015)... 2015 Parents need to start the ... substance use disorders. School programs like DARE, or Drug ... NOPE, or Narcotics Overdose Prevention and Education has already ... Healthline News on Feb. 27th. As teens continue ... drugs, drug prevention proponents are lobbying Florida to pass ...
(Date:3/6/2015)... As the Association of American Medical Colleges' ... by 2025 is updated this week and debated in ... preparing by analyzing demographics and pursuing viable solutions for ... factors including the increasing number of retiring doctors, increasing ... Care Act and an uneven distribution of new doctors ...
Breaking Medicine News(10 mins):Health News:CNN’s Dr. Sanjay Gupta Among Headliners at American Telemedicine Association 2015 Annual Meeting 2Health News:Prevention Magazine Names Califia Farms Winner of 2015 Cleanest Packaged Food Award 2Health News:Prevention Magazine Names Califia Farms Winner of 2015 Cleanest Packaged Food Award 3Health News:Aging Population & Emphasis on Dental Care Drives the Dental Prosthetic & Implant Consumables Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population & Emphasis on Dental Care Drives the Dental Prosthetic & Implant Consumables Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:A Harbor Village Detox Clinical Psychologist Encourages School Programs like NOPE to Positively Impact Awareness of Substance Use Disorders 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 4
... of rivaroxaban cut risk of venous thromboembolism, study finds ... of the oral drug rivaroxaban helps prevent potentially fatal ... say. , The risk of venous thromboembolism (VTE) is ... persist after a patient leaves hospital. Current guidelines recommend ...
... Family -, LEXINGTON, Mass., June 25 Instrumentation Laboratory,(IL) ... the ACL,TOP software V3.0.0. This clearance allows IL to market ... States as a member of the ACL TOP,Family of analyzers., ... of the ACL,TOP Family, including the highly successful ACL TOP ...
... existing business in Philadelphia, New York and Phoenix, ... Melbourne, Fla., and San Antonio, BRENTWOOD, Tenn., ... care and care management services for,frail and chronically ... acquire Care Level Management of Woodland Hills, Calif. ...
... data indicates smokers may avoid medication when quitting, ... the safety of a prescription smoking cessation therapy. A ... and caused confusion,among a significant percentage of smokers who ... to quit. Moreover, the survey shows many smokers,are avoiding ...
... KONG, June 25 /Xinhua-PRNewswire-FirstCall/ -- Golden Meditech,Company Limited ... is pleased to announce its annual results for ... remarkable organic growth of core businesses,and exceptional gains ... of HK$713,653,000, a jump of 209% over last ...
... Executive,Director, Diana Fuentes-Michel today urged eligible nursing ... for college to immediately apply,for the 2007-08 academic ... programs. The deadline for applications is June 30, ... to be aware of all available,resources to help ...
Cached Medicine News:Health News:Oral Drug Helps Prevent Clotting After Hip Replacement 2Health News:Instrumentation Laboratory Launches ACL Top(R) 500 CTS Hemostasis Testing System 2Health News:INSPIRIS Acquires Care Level Management 2Health News:Recent Safety News About Smoking Cessation Therapies Leaving Smokers Confused, More Reluctant to Quit 2Health News:Recent Safety News About Smoking Cessation Therapies Leaving Smokers Confused, More Reluctant to Quit 3Health News:Recent Safety News About Smoking Cessation Therapies Leaving Smokers Confused, More Reluctant to Quit 4Health News:Recent Safety News About Smoking Cessation Therapies Leaving Smokers Confused, More Reluctant to Quit 5Health News:China's Leading Healthcare Market Player Records 200% Increase in Profits and Earnings 2Health News:Nursing Loan Forgiveness Programs -- More Applicants Needed by June 30, 2008 2
(Date:3/6/2015)... HILL, N.C. , March 6, 2015 /PRNewswire/ ... find it challenging to prove the value of ... advances in technology, along with plummeting resources, corporate ... According to recent research by benchmarking ... of change impacting corporate library services. Many companies ...
(Date:3/6/2015)... -- The Alliance for Safe Biologic Medicines ... on its approval of the first biosimilar to be ... Novartis, Zarxio (filgrastim-sndz), biosimilar to Amgen,s Neupogen (filgrastim), was ... advisory panel that it be approved for all five ... "The approval of the first biosimilar is a ...
(Date:3/6/2015)... CRANBURY, N.J. , March 6, 2015  Palatin Technologies, ... presenting at the 27 th Annual ROTH Conference on ... conference will be held at the Ritz Carlton Laguna Niguel ... Carl Spana , Ph.D., President and Chief Executive ... corporate and development programs. About Palatin ...
Breaking Medicine Technology:Forces of Change Impacting Corporate Library Services 2ASBM Commends FDA for Approval, Clear Naming of First Biosimilar 2
... Nov. 3, 2011 Dyadic International, Inc. ("Dyadic") ... on the discovery, development, manufacture and sale of ... enzyme and biopharmaceutical industries, today announced financial results ... (Logo: http://photos.prnewswire.com/prnh/20110621/CL06708LOGO) The financial information ...
... VIVUS, Inc. (NASDAQ: VVUS ) today announced that ... the peer-reviewed journal of The Obesity Society. The EQUIP study ... 1,267 severely obese (BMI >/= 35 kg/m 2 ) patients across ... of 14.4% of initial body weight among those who completed the ...
Cached Medicine Technology:Dyadic International Reports 2011 Third Quarter Financial Results 2Dyadic International Reports 2011 Third Quarter Financial Results 3Dyadic International Reports 2011 Third Quarter Financial Results 4Dyadic International Reports 2011 Third Quarter Financial Results 5Dyadic International Reports 2011 Third Quarter Financial Results 6Dyadic International Reports 2011 Third Quarter Financial Results 7Qnexa® Phase 3 Data Published In Obesity Show 14.4% Average Weight Loss In Severely Obese Patients Completing One Year Of Treatment 2Qnexa® Phase 3 Data Published In Obesity Show 14.4% Average Weight Loss In Severely Obese Patients Completing One Year Of Treatment 3Qnexa® Phase 3 Data Published In Obesity Show 14.4% Average Weight Loss In Severely Obese Patients Completing One Year Of Treatment 4Qnexa® Phase 3 Data Published In Obesity Show 14.4% Average Weight Loss In Severely Obese Patients Completing One Year Of Treatment 5Qnexa® Phase 3 Data Published In Obesity Show 14.4% Average Weight Loss In Severely Obese Patients Completing One Year Of Treatment 6
... hormone (FSH) is a glycoprotein hormone ... Like hCG, LH and TSH, the ... dimer consisting of alpha- and beta-subunits. ... by gonadotropin-releasing hormone (GnRH) from the ...
... Direct to High Res SSP kits provide high resolution ... Locus specific typing on a single tray reduces QC ... from genomic DNA to high resolution results, no need ... with a single tray , Unique reaction pattern for ...
... Res SSP kits provide high resolution typing of the ... on a single tray reduces QC and testing costs ... to high resolution results, no need for initial low ... tray , Unique reaction pattern for most common alleles ...
... SSP method utilizes allele-specific primer combinations in ... the principle that only primers whose sequence ... will be converted by the polymerase into ... no amplification product. Using the Biotest SSP ...
Medicine Products: